HIV - Results With New Integrase Inhibitor Plus FUZEON And Boosted Protease Inhibitor Show Undetectable Rate Of 98 Percent

Tue, 06 Mar 2007 09:00 PM EST

... Virtually all patients (98 percent) who received the investigational integrase inhibitor raltegravir, along with FUZEON ® (enfuvirtide) and an active boosted protease inhibitor (darunavir), achieved undetectable levels of HIV (less than 400 copies/mL of blood), according to new interim 16-week cl [click link for full article] ...